Report #2872611

Received Nov 13, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: Nov 2, 2025
Onset: Nov 3, 2025
Days to onset: 1
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	2	UNK	—

Symptoms (1)

Abdominal discomfort

Symptom narrative

Upset stomach; This non-serious case was reported by a consumer via call center representative and described the occurrence of upset stomach in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On 02-NOV-2025, the patient received the 2nd dose of Shingrix. On 03-NOV-2025, 1 days after receiving Shingrix, the patient experienced upset stomach (Verbatim: Upset stomach). The outcome of the upset stomach was unknown. It was unknown if the reporter considered the upset stomach to be related to Shingrix. It was unknown if the company considered the upset stomach to be related to Shingrix. Additional Information: GSK Receipt Date: 05-NOV-2025 Caller reported that her son started to experience an upset stomach 2 days after receiving the second dose of Shingrix. Patient date of birth, initials were not available.